Published in Gene Therapy Weekly, October 28th, 2004
The data were reported in a poster presentation by Dr. Eric Rowinsky, clinical professor of Medicine, University of Texas Health Science Center and senior scientist, CTRC Institute for Drug Development, San Antonio, Texas.
This ongoing study is a phase I dose-escalation clinical trial. Sixteen men and women between the ages of 29 and 81 (mean 58 years) with various...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.